Fort Sheridan Advisors LLC
Source: SEC Form 13F · as of Mar 2026Fort Sheridan Advisors LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $59.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$59.6M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 68,168 | $14.8M |
| JNJJOHNSON & JOHNSON | 50,530 | $12.4M |
| MRKMerck & Co., Inc. | 98,611 | $11.9M |
| LLYELI LILLY & Co | 5,324 | $4.9M |
| PFEPFIZER INC | 117,070 | $3.3M |
| AMGNAMGEN INC | 8,433 | $3.0M |
| NVSNovartis AG | 13,529 | $2.1M |
| ABTABBOTT LABORATORIES | 17,836 | $1.8M |
| GMOptec International, Inc. | 18,008 | $1.3M |
| BMYBRISTOL MYERS SQUIBB CO | 14,870 | $902K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,674 | $748K |
| GILDGILEAD SCIENCES, INC. | 4,830 | $673K |
| MGTXMeiraGTx Holdings plc | 66,860 | $579K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,701 | $563K |
| AZNASTRAZENECA PLC | 1,140 | $225K |
| REGNREGENERON PHARMACEUTICALS, INC. | 280 | $216K |
| PMPhilip Morris International Inc | 1,297 | $214K |
| GERNGERON CORP | 10,000 | $15K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.